Geldanamycin as a potential anti-cancer agent: Its molecular target and biochemical activity

被引:274
作者
Neckers, L [1 ]
Schulte, TW [1 ]
Mimnaugh, E [1 ]
机构
[1] NCI, Dept Cell & Canc Biol, Med Branch, Rockville, MD USA
关键词
Hsp90; chaperone; geldanamycin; benzoquinone ansamycin;
D O I
10.1023/A:1006382320697
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heat shock protein 90 is one of the most abundant cellular proteins. Although its functions are still being characterized, it appears to serve as a chaperone for a growing list of cell signaling proteins, including many tyrosine and serine/threonine kinases, involved in proliferation and/or survival. The benzoquinone ansamycin geldanamycin has been shown to bind to Hsp90 and to specifically inhibit this chaperone's function, resulting in client protein destabilization. Its ability to simultaneously stimulate depletion of multiple oncogenic proteins suggests that geldanamycin, or other molecules capable of targeting Hsp90 in cancer cells, may be of clinical benefit.
引用
收藏
页码:361 / 373
页数:13
相关论文
共 118 条
[1]  
Akagi T, 1996, ONCOGENE, V13, P399
[2]  
AKNER G, 1992, EUR J CELL BIOL, V58, P356
[3]   A ROLE FOR HSP90 IN CELL-CYCLE CONTROL - WEE1 TYROSINE KINASE-ACTIVITY REQUIRES INTERACTION WITH HSP90 [J].
ALIGUE, R ;
AKHAVANNIAK, H ;
RUSSELL, P .
EMBO JOURNAL, 1994, 13 (24) :6099-6106
[4]   Depletion of p185(erbB2), Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity [J].
An, WG ;
Schnur, RC ;
Neckers, L ;
Blagosklonny, MV .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (01) :60-64
[5]   Selective interaction of hsp90 with an estrogen receptor ligand-binding domain containing a point mutation [J].
Aumais, JP ;
Lee, HS ;
Lin, R ;
White, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) :12229-12235
[6]   An atypical topoisomerase II from archaea with implications for meiotic recombination [J].
Bergerat, A ;
deMassy, B ;
Gadelle, D ;
Varoutas, PC ;
Nicolas, A ;
Forterre, P .
NATURE, 1997, 386 (6623) :414-417
[7]   Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90 [J].
Blagosklonny, MV ;
Toretsky, J ;
Bohen, S ;
Neckers, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8379-8383
[8]  
BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933
[9]   ISOLATION OF HSP90 MUTANTS BY SCREENING FOR DECREASED STEROID-RECEPTOR FUNCTION [J].
BOHEN, SP ;
YAMAMOTO, KR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11424-11428
[10]   INTERACTION BETWEEN THE ROUS-SARCOMA VIRUS TRANSFORMING PROTEIN AND 2 CELLULAR PHOSPHOPROTEINS - ANALYSIS OF THE TURNOVER AND DISTRIBUTION OF THIS COMPLEX [J].
BRUGGE, J ;
YONEMOTO, W ;
DARROW, D .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (01) :9-19